Corinna Kosnopfel
11PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Oct 16, 2025
Combinatorial ERK Inhibition Enhances MAPK Pathway Suppression in BRAF-Mutant Melanoma.Corinna Kosnopfel, Tobias Sinnberg, Shrunal Mane
|Apr 18, 2025
LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapies.Yang Li, Corinna Kosnopfel, Daniela Schwammbach
|May 29, 2024
Loss of p14 diminishes immunogenicity in melanoma via non-canonical Wnt signaling by reducing the peptide surface density.Jonas Wohlfarth, Corinna Kosnopfel, Dominic Faber
|May 11, 2024
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils.Simone Wendlinger, Jonas Wohlfarth, Claudia Siedel
|Dec 09, 2023
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma.Heike Niessner, Anna Hüsch, Corinna Kosnopfel
|Jul 18, 2023
Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.Corinna Kosnopfel, Simone Wendlinger, Heike Niessner
Pageof 2
Frequent Collaborators
5 joint publications
Bastian Schilling
4 joint publications
Tobias Sinnberg
2 joint publications
David Schrama
2 joint publications
Jonas Wohlfarth
2 joint publications
Heike Niessner
2 joint publications
Birgit Fehrenbacher
2 joint publications
Matthias Goebeler
2 joint publications
Kilian Wistuba-Hamprecht
2 joint publications
Markus V Heppt
1 joint publications
K Maurus
